System-Specific Epigenetic Aging Signatures in Autistic Adults
- 1UCLA
Abstract
Background: Autism is a lifelong neurodevelopmental condition, but the biological processes shaping aging are poorly understood. DNA methylation-based measures index physiological decline and mortality risk independently of chronological age. We tested whether biological aging differs in autistic adults, whether differences are system-specific, and which factors predict within-autism variation. Methods: Saliva DNA methylation (Illumina EPIC) was assayed in 37 autistic adults (31 male, 6 female; mean age 29.8 years), followed from early childhood, spanning a broad ability range including intellectual disability, and 188 non-autistic adults from four public datasets, processed jointly. Fifteen measures were calculated: four global (Horvath, GrimAge, DunedinPACE, SystemsAge) and 11 system-specific SystemsAge subscores. Models adjusted for age, sex, and epithelial-cell proportion. Results: Global aging measures did not differ between groups (all q > .34). However, autistic adults had higher Brain ({beta} = 0.81), Blood ({beta} = 0.65), and Liver SystemsAge ({beta} = 0.58; all q < .01), with Brain and Blood robust across sensitivity analyses. Within autism, aging measures were unrelated to symptom severity, IQ, co-occurring diagnoses, or medication use. Instead, elevations were associated with psychosocial circumstances, including a lack of structured daytime activity, greater loneliness, and lower quality of life. Conclusions: Differences in aging biology in autism appeared system-specific rather than global, with no evidence of generalized epigenetic age acceleration. This vulnerability appeared more closely tied to psychosocial factors than core clinical features. System-specific DNAm measures may therefore provide a more sensitive framework for identifying biological heterogeneity and potentially modifiable contributors to healthy aging in autistic adulthood.
Related
- Development of a Communication Characteristics Module for Autistic Adults and the Creation of a Communication Profile Variable
- Social brain fingerprinting: unique functional connectomes underpin interpersonal behaviours in non-autistic and autistic adults
- Transcriptomic Signatures Suggest Epigenetic Programming of Molecular Defense in Biochar-Exposed Formica japonica
- Altered adaptive mentalization in autistic adults
- Dynamic excitatory-inhibitory differences in autistic and non-autistic adults: Evidence from a pharmacological challenge with arbaclofen
BibTeX
@misc{dickinson2026systemspecific,
title = {{System-Specific Epigenetic Aging Signatures in Autistic Adults}},
author = {A. Dickinson and C. R. Lewis and D. H. Geschwind and J. E. Carroll and C. Lord},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.12.751174},
url = {https://www.biorxiv.org/content/10.64898/2026.09.12.751174v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - System-Specific Epigenetic Aging Signatures in Autistic Adults
AU - A. Dickinson
AU - C. R. Lewis
AU - D. H. Geschwind
AU - J. E. Carroll
AU - C. Lord
PY - 2026
DA - 2026/09/12
PB - bioRxiv
DO - 10.64898/2026.09.12.751174
UR - https://www.biorxiv.org/content/10.64898/2026.09.12.751174v1
AB - Background: Autism is a lifelong neurodevelopmental condition, but the biological processes shaping aging are poorly understood. DNA methylation-based measures index physiological decline and mortality risk independently of chronological age. We tested whether biological aging differs in autistic adults, whether differences are system-specific, and which factors predict within-autism variation. Methods: Saliva DNA methylation (Illumina EPIC) was assayed in 37 autistic adults (31 male, 6 female; mean age 29.8 years), followed from early childhood, spanning a broad ability range including intellectual disability, and 188 non-autistic adults from four public datasets, processed jointly. Fifteen measures were calculated: four global (Horvath, GrimAge, DunedinPACE, SystemsAge) and 11 system-specific SystemsAge subscores. Models adjusted for age, sex, and epithelial-cell proportion. Results: Global aging measures did not differ between groups (all q > .34). However, autistic adults had higher Brain ({beta} = 0.81), Blood ({beta} = 0.65), and Liver SystemsAge ({beta} = 0.58; all q < .01), with Brain and Blood robust across sensitivity analyses. Within autism, aging measures were unrelated to symptom severity, IQ, co-occurring diagnoses, or medication use. Instead, elevations were associated with psychosocial circumstances, including a lack of structured daytime activity, greater loneliness, and lower quality of life. Conclusions: Differences in aging biology in autism appeared system-specific rather than global, with no evidence of generalized epigenetic age acceleration. This vulnerability appeared more closely tied to psychosocial factors than core clinical features. System-specific DNAm measures may therefore provide a more sensitive framework for identifying biological heterogeneity and potentially modifiable contributors to healthy aging in autistic adulthood.
ER -